by David Brindley | Apr 22, 2013
. Within the past few weeks, we have all lost someone who has impacted our lives. And this I can guarantee. On Monday 8th April 2013, I woke up, grabbed my tennis bag and headed for a morning hit. In the car, I heard the lacquered voice of the BBC’s John Humphrys...
by Holly Wobma | Apr 9, 2013
“A Rat’s Past Lives, a Giraffe and Bull” depicts the interaction between the extracellular matrix and differentiated hematopoietic stem cells. Image by Elizabeth Cambridge from the Cells I See library . If you Google the term “stem cells”, you will...
by Paul Krzyzanowski | Mar 16, 2013
. As a follow up to last month’s post describing how leaked information about an Alzheimer’s drug clinical trial led to the largest ever case of insider trading and destroyed the careers of Dr. Sidney Gilman, a well-respected clinician, and Matthew Martoma, a young...
by Paul Krzyzanowski | Mar 13, 2013
[pullquote]In time, this purchase might make BioTime the company that Geron was supposed to be.[/pullquote]Avid watchers of the stem cell and regenerative medicine market have no doubt heard of Geron selling its stem cell assets to BioTime. Nature covered it in some...
by Holly Wobma | Feb 5, 2013
. I am, admittedly, the least ambitious type of gym-goer. I don’t train for marathons. I don’t try to body-build – the bar is set pretty low (and, incidentally, also the resistance!). All I want to accomplish is to get rid of some of my “extra skin” and replace it...
by Lisa Willemse | Jan 14, 2013
We’ve posted several times in the past on exhibits and events where stem cells feature not just as a subject of scientific study, but as works of art. In this we are not alone — in addition to our own Cells I See art contest, shows at the Ontario Science...
Comments